ChastreJ, FagonJY. Ventilator-associated pneumonia. Am J Respir Crit Care Med, 2002; 165(7):867–903.
2.
American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med, 2005; 171(4):388–416.
3.
MüllerB, BeckerKL. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly, 2001; 131(41–42):595–602.
4.
MüllerB, WhiteJC, NylénES, SniderRHJr, BeckerKL, HabenerJF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab, 2001; 86(1):396–404.
5.
NylénES, WhangKT, SniderRHJr, SteinwaldPM, WhiteJC, BeckerKL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med, 1998; 26(6):1001–1006.
6.
WagnerKE, MartinezJM, VathSD, SniderRH, NylénES, BeckerKL, et al. Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs. Crit Care Med, 2002; 30(10):2313–2321.
7.
BeckerKL, NylénES, SniderRHJr, MüllerB, WhiteJC. Immunoneutralization of procalcitonin as therapy of sepsis. J Endotoxin Res, 2003; 9(6):367–374.
8.
SimonL, GauvinF, AmreDK, Saint-LouisP, LacroixJ. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis, 2004; 39(2):206–217. Erratum in: Clin Infect Dis 2005;40(9):1386-1388.
9.
UzzanB, CohenR, NicolasP, CucheratM, PerretGY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med, 2006; 34:1996–2003.
10.
ChastreJ, LuytCE, TrouilletJL, CombesA. New diagnostic and prognostic markers of ventilator-associated pneumonia. Curr Opin Crit Care, 2006; 12(5):446–451.
11.
DallasJ, BrownSM, HockK, ScottMG, SkrupkyLP, BoyleWA, KollefMH. Diagnostic utility of plasma procalcitonin for nosocomial pneumonia in the intensive care unit setting. Respir Care, 2011; 56(4):412–419.
12.
DufloF, DebonR, MonneretG, BienvenuJ, ChassardD, AllaouchicheB. Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology, 2002; 96(1):74–79.
13.
LuytCE, GuerinV, CombesA, TrouilletJL, AyedSB, BernardM, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med, 2005; 171(1):48–53.
14.
SeligmanR, MeisnerM, LisboaTC, HertzFT, FilippinTB, FachelJM, et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care, 2006; 10(5):R125.
15.
JungB, EmbriacoN, RouxF, ForelJM, DemoryD, Allardet-ServentJ, et al. Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score. Intensive Care Med, 2010; 36(5):790–798.
16.
RamirezP, GarciaMA, FerrerM, AznarJ, ValenciaM, SahuquilloJM, et al. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J, 2008; 31(2):356–362.
17.
LuytCE, CombesA, ReynaudC, HekimianG, NieszkowskaA, TonnellierM, et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med, 2008; 34(8):1434–1440.
18.
StolzD, SmyrniosN, EggimannP, ParggerH, ThakkarN, SiegemundM, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J, 2009; 34(6):1364–1375.
19.
BouadmaL, LuytCE, TubachF, CraccoC, AlvarezA, SchwebelC, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet, 2010; 375(9713):463–474.